[1]
“COMPARISON OF SITAGLIPTIN VERSUS SULFONYLUREAS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS”, FMHR, vol. 3, no. 2, pp. 1069–1075, Apr. 2025, Accessed: Sep. 04, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1271